Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Electrophysiological patterns of oropharyngeal swallowing in multiple sclerosis.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination.
Few patients with neurodegenerative disorders require spinal surgery.
High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction.
The use of telemedicine in patients with multiple sclerosis.
Quantitative MRI for Analysis of Active Multiple Sclerosis Lesions without Gadolinium-Based Contrast Agent.
Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus.
Short-term safety of pulse steroid therapy in multiple sclerosis relapses.
Activated Invariant NKT Cells Control Central Nervous System Autoimmunity in a Mechanism That Involves Myeloid-Derived Suppressor Cells.
Alemtuzumab in multiple sclerosis: latest evidence and clinical prospects.
Driving performance in persons with mild to moderate symptoms of multiple sclerosis.
Sex-specific control of CNS autoimmunity by p38 MAPK signaling in myeloid cells.
[Clinical and epidemiological aspects of multiple sclerosis in the Moscow region.]
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
Targeting Dynamic Balance in Falls-Prevention Interventions in Multiple Sclerosis: Recommendations from the International MS Falls Prevention Research Network.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
Obtaining from Grape Pomace an Enzymatic Extract with Anti-inflammatory Properties.
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
Magnetic Resonance Spectroscopy: A Possible In Vivo Marker of Disease Progression for Multiple Sclerosis?
Do Not Miss the Eye in Acute Demyelinating Encephalomyelitis.
So many progenitors, so little myelin.
Glatiramer acetate to treat multiple sclerosis during pregnancy and lactation: a safety evaluation.
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

Pages